Respiratory Insufficiency: Clinical Trials

116 trials for Respiratory Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

61 completed, 16 unknown, 14 terminated, 10 recruiting. 116 Phase 2, 19 Phase 3, 16 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2116Completed 61, Unknown 16, Terminated 14, Recruiting 10, Withdrawn 9, Active not recruiting 3, Not yet recruiting 3
Phase 319Completed 10, Unknown 4, Terminated 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 116Completed 13, Terminated 2, Withdrawn 1

Follow Respiratory Insufficiency: new trials by email Literature Review of Respiratory Insufficiency trials Research Report on Respiratory Insufficiency

Trials (filtered) newest first · largest first

All 116 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs
Intranasal Oxytocin 40 i.u., Intranasal Placebo Spray - Obesity & Overweight, Respiratory Depression
Phase 2Not yet recruitingGeorge Washington University1002027-05-152026-10-29
ENA-001 for Post Operative Respiratory Depression (PORD)
ENA-001 - Respiratory Depression
Phase 2Not yet recruitingEnalare Therapeutics Inc.2002026-12-152026-02-27
A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)
Non-invasive ventilation - Amyotrophic Lateral Sclerosis (ALS), Chronic Respiratory Failure
Phase 2RecruitingUniversity of Pennsylvania482026-06-112026-06-26
Study to Investigate the Efficacy and Safety of Apomivir®
Apomivir®, Placebo - Influenza
Phase 2Not yet recruitingFar East Bio-Tec Co., Ltd1962026-05-312025-05-14
A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
agenT-797, Placebo, Standard of Care (SOC) - Pneumonia
Phase 2RecruitingMiNK Therapeutics902026-05-262026-06-26
A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults
Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction
Phase 2CompletedBayer1202026-04-202026-06-08
Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients
Esophageal pressure-guided PEEP titration, Standard care PEEP management - Respiratory Failure
Phase 2RecruitingUniversity of Alberta302026-02-052026-04-13
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
Oxymetazoline + Triamcinolone - Nasal Obstruction, Chronic Rhinitis
Phase 2TerminatedWashington University School of Medicine32025-11-102026-03-23
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
Tocilizumab (Actemra®), Dexamethasone - Acute Hypoxemic Respiratory Failure
Phase 2RecruitingLorenzo delSorbo602025-10-202026-10-09
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
The COMBO Endoscopy Oropharyngeal Airway - Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice
Phase 2RecruitingZhejiang University502025-06-122025-06-24
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
Supraglottic Oxygen Delivery via an Endotracheal Tube - Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice
Phase 2RecruitingZhejiang University502025-06-122025-07-17
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
PF-07275315, Placebo - Asthma
Phase 2RecruitingPfizer2522025-05-202026-11-06
Sedation vs No Sedation in Mechanically Ventilated COPD Patients
Midalozam - Chronic Obstructive Pulmonary Disease, Respiratory Failure
Phase 2CompletedAl-Azhar University1002025-04-142026-06-02
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
MRG-001 (Low-dose), MRG-001 (High-dose), Placebo - Acute Respiratory Distress Syndrome, Respiratory Failure
Phase 2UnknownMedRegen LLC602024-12-012024-08-23
Nasal Obstruction With Oxymetazoline and Corticosteroids
Oxymetazoline Nasal Spray, Budesonide nasal spray - Nasal Obstruction
Phase 2RecruitingWashington University School of Medicine802024-10-152025-09-11
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Rhu-pGSN, normal saline - Acute Respiratory Distress Syndrome, Infections
Phase 2RecruitingBioAegis Therapeutics Inc.6002024-10-032026-10-20
Biological Effects of Quercetin in COPD Phase II
Quercetin 1000 mg, Quercetin 500 MG, Placebo - Chronic Obstructive Pulmonary Disease, Emphysema
Phase 2UnknownTemple University302023-11-012024-04-08
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
Nalbuphine hydrochloride injection, Hydromorphone hydrochloride injection - Respiratory Insufficiency
Phase 2 / Phase 3RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology2042023-08-302025-01-21
Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age
Remifentanil Hydrochloride, Pupillometry measurement - Opioid Toxicity, Pupillary Miosis
Phase 2 / Phase 3CompletedUniversity of California, San Francisco102022-10-012025-05-02
Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Tetralogy of Fallot, Pulmonary Insufficiency
Phase 1 / Phase 2CompletedNemours Children's Clinic252022-08-232026-04-27

Showing 20 of 116. Sign in to see all of them.

Narrower conditions

COVID-19 (24)  ·  Respiratory Distress Syndrome (18)  ·  Nasal Obstruction (16)  ·  Airway Obstruction (8)  ·  Coronavirus Infections (7)  ·  Critical Illness (7)  ·  Acute Lung Injury (6)  ·  Hypoxia (6)  ·  Pneumonia (6)  ·  Pulmonary Disease, Chronic Obstructive (6)  ·  Dyspnea (5)  ·  Pancreatitis (4)  ·  Asthma (3)  ·  Hypertension, Pulmonary (3)

Broader conditions

Respiration Disorders (116)  ·  Respiratory Tract Diseases (114)  ·  Pathological Conditions, Signs and Symptoms (47)  ·  Lung Diseases (46)  ·  Infections (37)  ·  Respiratory Tract Infections (29)  ·  Virus Diseases (29)  ·  RNA Virus Infections (28)  ·  Signs and Symptoms (28)  ·  Coronaviridae Infections (26)  ·  Nidovirales Infections (26)  ·  Pathologic Processes (25)  ·  Pneumonia, Viral (22)  ·  Pneumonia (20)

Interventions

Standard of Care (6)  ·  Saline Solution (5)  ·  Dexamethasone (4)  ·  Dexmedetomidine (3)  ·  Oxymetazoline (3)  ·  Sodium Chloride (3)  ·  Aspirin (2)  ·  Culture Media (2)  ·  Glucose (2)  ·  Morphine (2)  ·  Nitric Oxide (2)  ·  Noninvasive Ventilation (2)  ·  Remifentanil (2)  ·  angiotensin I (1-7) (2)  ·  aviptadil (2)

Sponsors

GlaxoSmithKline (5)  ·  NICHD Neonatal Research Network (3)  ·  Novartis Pharmaceuticals (3)  ·  Erasme University Hospital (2)  ·  Johns Hopkins University (2)  ·  KK Women's and Children's Hospital (2)  ·  Mackay Memorial Hospital (2)  ·  Patrick Murphy (2)  ·  University of Turin, Italy (2)  ·  Washington University School of Medicine (2)  ·  Zhejiang University (2)  ·  5i Sciences, Inc. (1)  ·  APR Applied Pharma Research s.a. (1)  ·  AbbVie (1)  ·  Abraham Edgar Gracia-Ramos (1)

Countries

United States (58)  ·  Canada (8)  ·  Italy (8)  ·  United Kingdom (7)  ·  Germany (6)  ·  Brazil (5)  ·  Taiwan (5)  ·  China (4)  ·  Spain (4)  ·  Argentina (3)  ·  Australia (3)  ·  Belgium (3)  ·  Denmark (3)  ·  Hungary (3)  ·  Netherlands (3)

Top investigators

Chao-Hsien Lee, MD (2)  ·  Mouen Khashab, MD (2)  ·  Abhik Das, PhD (1)  ·  Abraham Edgar Gracia-Ramos, MD MSc (1)  ·  Adrienne Randolph, MD (1)  ·  Ajit Limaye, MD (1)  ·  Amber U Luong, MD, PhD (1)  ·  Ana Martins Valle (1)  ·  Anders Perner, MD, PhD (1)  ·  Atsushi Kawaguchi (1)  ·  Ban L Sng, FANZCA (1)  ·  Ban Leong Sng, MBBS, MMED (1)

Results publications

PMID 25496504, PMID 31209698, PMID 34473343, PMID 15141377, PMID 15725047, PMID 16424722, PMID 16540947, PMID 17605780, PMID 19183804, PMID 20920189, PMID 20937093, PMID 22315264, PMID 22465313, PMID 22791092, PMID 23622977, PMID 23784924, PMID 23849147, PMID 23907810, PMID 23919993, PMID 24038922, PMID 26728475, PMID 27059469, PMID 27110692, PMID 27178892, PMID 27419080, PMID 28528348, PMID 28606907, PMID 28829877, PMID 29209510, PMID 29264361, PMID 29800001, PMID 29866165, PMID 29975735, PMID 30154874, PMID 30558653, PMID 30850876, PMID 30956804, PMID 31119695, PMID 31352795, PMID 31455384, PMID 31741746, PMID 31921715, PMID 31986264, PMID 32071149, PMID 32142651, PMID 32155444, PMID 32192578, PMID 32212240, PMID 32227760, PMID 32246450

NIH funding

U10HD036790 (3), U10HD021385 (2), U10HD027880 (2), U10HD034216 (2), U10HD040492 (2), U10HD040689 (2), U10HD053109 (2), 2009 (1), 2019 (1), R01HL084139 (1), R01HL130881 (1), R21NR012795 (1), R33AT009991 (1), U01HL102235 (1), U01HL102547 (1)